Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Κύριοι συγγραφείς: | Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL |
---|---|
Μορφή: | Conference item |
Γλώσσα: | English |
Έκδοση: |
Springer
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
ανά: Teoh, E, κ.ά.
Έκδοση: (2017) -
Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
ανά: Scott, NP, κ.ά.
Έκδοση: (2021) -
Cancer imaging with fluciclovine (18F)
ανά: Teoh, E
Έκδοση: (2018) -
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
ανά: Morotti, M, κ.ά.
Έκδοση: (2020) -
Glutamine deprivation alters the origin and function of cancer cell exosomes
ανά: Fan, S, κ.ά.
Έκδοση: (2020)